Pruritus, or chronic itch, remains one of the most distressing and quality-of-life impairing symptoms in dermatology. Over the past decade, understanding of the neuroimmune mechanisms driving itch has advanced dramatically, leading to the emergence of biologics and small molecules that target its molecular pathways. This review summarizes current and investigational therapies for atopic dermatitis (AD), psoriasis, and chronic spontaneous urticaria (CSU)—3 major pruritic dermatoses—while addressing real-world challenges in dermatologic practice.